chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Petechia to face and chest developed prior to vomiting; nausea and vomiting.; Petechia to face and chest developed prior to vomiting; nausea and vomiting.; Petechia to face and chest developed prior to vomiting; nausea and vomiting.; This is a spontaneous report received from a contactable reporter(s) (Physician).  A 6 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 24Nov2021 13:00 (Lot number: FL00007) at the age of 6 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "AUTISM" (unspecified if ongoing); "INSOMNIA" (unspecified if ongoing); "COVID-19" (unspecified if ongoing), notes: if covid prior vaccination: YES. The patient's concomitant medications were not reported. Past drug history included: None. The following information was reported: NAUSEA (non-serious), PETECHIAE (non-serious), VOMITING (non-serious) all with onset 24Nov2021 13:30, outcome "recovering" and all described as "Petechia to face and chest developed prior to vomiting; nausea and vomiting.". The event "petechia to face and chest developed prior to vomiting; nausea and vomiting.", "petechia to face and chest developed prior to vomiting; nausea and vomiting." and "petechia to face and chest developed prior to vomiting; nausea and vomiting." was evaluated at the emergency room visit. Therapeutic measures were not taken as a result of nausea, petechiae, vomiting.  Additional Information: Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient was diagnosed with COVID-19 prior vaccination. Patient has not been tested for COVID-19 since vaccination. The patient was not received treatment for the adverse events. The patient was no known allergies.  Follow-Up#1 (01Dec2021): Follow-up attempts are completed. No further information is expected.  No follow-up attempts are possible. No further information is expected.
Initial report received from a healthcare professional (physician) on 04 June 2013. A five year old male patient received his 5th dose of DAPTACEL in the Dtap series on 14 May 2013 into the left deltoid, route not reported (Batch C4346BA). The patient also received a MMR vaccine, Manufacturer Merck, (Batch H015826) into the right deltoid, route not reported on 14 May 2013. The reporter denied that the patient had any concomitant medications or medical history. The patient experienced a site reaction (side not reported) of redness, swelling and tenderness resembling cellulitis. The patient was examined by a physician on 16 May 2013 and treated with KEFLEX, ice compresses and Ibuprofen, details not provided. Laboratory tests were not reported. The patient recovered on an unreported date. No further details were available at the time of this report. Documents held by sender: None.
This spontaneous report as received from a medical assistant refers to a 17 year old patient of unknown gender. The patient's drug allergies and pertinent medical history was not reported. On 02-JUL-2014 the patient was vaccinated with second dose of VAQTA (dose, frequency and route of administration were not reported) (lot # J014584 and expiry date: 16-JAN-2016) which was stored improperly. No adverse effects were noted. No product quality complaint was reported for VAQTA. This case is linked to 1407USA010956, 1407USA012902, 1407USA012903, 1407USA012904, , 1407USA012905, 1407USA012906, 1407USA012907, 1407USA012908, 1407USA012909, 1407USA012910, 1407USA012911, 1407USA012912, 1407USA012913, 1407USA012914, 1407USA012915, 1407USA012916, 1407USA012917, 1407USA012918, 1407USA012919, 1407USA012920, 1407USA012921, 1407USA012922, 1407USA012923, 1407USA012924, 1407USA012925, 1407USA012926, 1407USA012927, 1407USA012928, 1407USA012929, 1407USA012930, 1407USA012931, 1407USA012932, 1407USA012933, 1407USA012934, 1407USA012935, 1407USA012936, 1407USA012937, 1407USA012938, 1407USA012939, 1407USA012940, 1407USA012941, 1407USA012942, 1407USA012943, 1407USA012944, 1407USA012945, 1407USA012946, 1407USA012947, 1407USA012948, 1407USA012949, 1407USA012950, 1407USA012951, 1407USA012952, 1407USA012953, 1407USA012954, 1407USA012955, 1407USA012956, 1407USA012957, 1407USA012958, 1407USA012959, 1407USA012960, 1407USA012961, 1407USA012962, 1407USA012963, 1407USA012964, 1407USA012965, 1407USA012966, 1407USA012967, 1407USA012968, 1407USA012969, 1407USA012970, 1407USA012971, 1407USA012972, 1407USA012973, 1407USA012974, 1407USA012975, 1407USA012976, 1407USA012977, 1407USA012978, 1407USA012979, 1407USA012980, 1407USA012981, 1407USA012982, 1407USA012983, 1407USA012984, 1407USA012985, 1407USA012987, 1407USA012988, 1407USA012990, 1407USA012991, 1407USA012992, 1407USA012993, 1407USA012994, 1407USA012995, 1407USA012996, 1407USA012997, 1407USA012998, 1407USA012999, 1407USA013000, 1407USA013013 and 1407USA01304 (same reporter link).
My left arm started to get hives. I have a tattoo and it?s only in the spots that have color.
After receiving the vaccine, 2 days later I have started my period which I haven?t had in 5 years as I have been on the birth control Nexplanon.
Information has been received from a registered nurse referring to an unknown number of patients of unknown age and gender. The patient's medical history and concurrent condition were not provided. On unspecified dates the patients were vaccinated with oral, ROTATEQ (dosage, strength and lot # were not reported), which had been improperly stored. At the time of the report, no adverse effects were reported. This is one of several report from the same reporter. Additional information has been requested.
Reservist had smallpox vaccination eight days ago c/o three days pain at site (LUA), pain in L neck and L shoulder. No fever or chills. Physical exam reveals "severe induration of vaccine site and lymphadenopathy of axilla or bubclavian on L arm." The follow up states " I do no know the lot number."
CONFIRMED COVID-19 INFECTION; This spontaneous report received from a health care professional concerned a female of unspecified age. The patient's weight was 106.59 kilograms, and height was 168 centimeters. The patient's concurrent conditions included: pre-diabetes, sleep apnea, hemorrhage, and hypothyroidism (low thyroid), and other pre-existing medical conditions included: Patient is a nurse. Her blood pressure was fine at the time of this report. The patient was not taking any medicine. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for covid-19 prophylaxis. The batch number was not reported and has been requested. No concomitant medications were reported.  On 03-JUL-2022, Laboratory data included: COVID-19 virus test Positive. On 08-JUL-2022, Laboratory data included: COVID-19 virus test Positive. On 09-JUL-2022, Laboratory data included: COVID-19 virus test Negative. On 12-JUL-2022, Laboratory data included: COVID-19 virus test Positive. On an unspecified date, the patient experienced confirmed covid-19 infection. Laboratory data (dates unspecified) included: COVID-19 virus test Positive. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of confirmed covid-19 infection was not reported. This report was non-serious. This report was associated with product quality complaint: 90000244864.; Sender's Comments: V0-Medical assessment comment not required as per standard procedure as the case was assessed as non-serious.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021 at 9:42 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 12-Jan-2021 at 9:42 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 74.26. No concomitant medications were reported. Batch number 041L20A administered on 12-Jan-2021 underwent temperature excursion with temperature range of 34 degrees Fahrenheit from 08:00 AM to 09:00 AM. This vial was moved to fridge on 08-Jan-2021 and beyond use date for the vial was reported as 07-Feb-2021. Product moved to clinic on 12-Jan-2021. Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34 or 35-degree Fahrenheit. Temperature recordings were taken using a traceable temperature monitor at every hour. No treatment medications were reported.
Pt received expired vaccine, TriHiBit (DTaP + HIB) contacted mom, child will be brought in on or before 18 month well check for revaccination.
Burning sensation at injection site; This is a spontaneous report from a contactable nurse received via a Pfizer sales representative. A patient of unspecified age and gender received pneumococcal 13-valent conjugate vaccine (diphtheria CRM197 protein) (PREVNAR 13), via an unspecified route of administration on an unspecified date at a single dose for immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced burning sensation at injection site on an unspecified date. The outcome of the event was unknown.  No follow-up attempts are possible. No further information is expected.
Chest tightness/tightness feeling in the sternum area; difficulty taking deep breaths; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (Chest tightness/tightness feeling in the sternum area) and DYSPNOEA (difficulty taking deep breaths) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     no medical history reported.  Concomitant products included PROBIOTICS NOS and ERGOCALCIFEROL (VITAMIN D [ERGOCALCIFEROL]) for an unknown indication.    On 07-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced CHEST DISCOMFORT (Chest tightness/tightness feeling in the sternum area) and DYSPNOEA (difficulty taking deep breaths). The patient was treated with ALBUTEROL [SALBUTAMOL] for Difficulty breathing, at an unspecified dose and frequency. At the time of the report, CHEST DISCOMFORT (Chest tightness/tightness feeling in the sternum area) and DYSPNOEA (difficulty taking deep breaths) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Tinnitus in both ears, constant ringing. Began with constant whooshing sound, progressed to constant ringing in both ears within a couple days. It's been over a week.
Patient temp elevated to 104 suddenly and patient started to have a seizure was taken to ER where temperature was reduced and seizures stopped.
Severe pain in the left foot (tarsals area), very weak and I wasn't able to walk it and it lasted for a day.  I applied cold compressed and it helped with the pain.  I was able to walk the next day.
High dose flu vaccine given 9/20/11. Complaints of shortness of breath and feeling of throat closing and vomiting 9/20/11 (Admitted to hospital with diagnosis of sepsis). Discharged 9/22/11. Diagnosis Bronchitis. Office visit recheck 9/27/11 without complaints.
heart thickening; heart murmur; night sweats; haven't gotten the second one; This spontaneous case was reported by a consumer and describes the occurrence of CARDIAC HYPERTROPHY (heart thickening) and CARDIAC MURMUR (heart murmur) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CARDIAC HYPERTROPHY (heart thickening) (seriousness criterion hospitalization), CARDIAC MURMUR (heart murmur) (seriousness criterion hospitalization), NIGHT SWEATS (night sweats) and PRODUCT DOSE OMISSION ISSUE (haven't gotten the second one). The patient was hospitalized from 16-May-2021 to 09-Jun-2021 due to CARDIAC HYPERTROPHY and CARDIAC MURMUR. At the time of the report, CARDIAC HYPERTROPHY (heart thickening), CARDIAC MURMUR (heart murmur), NIGHT SWEATS (night sweats) and PRODUCT DOSE OMISSION ISSUE (haven't gotten the second one) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported by reporter. Treatment medication not reported.  Company comment:  Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
throwing up; weak, cannot stand on his own; sour/foul taste in mouth; feeling frozen; nauseated; chills; Leg muscles are sore; headache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VOMITING (throwing up) and ASTHENIA (weak, cannot stand on his own) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included SALBUTAMOL SULFATE (VENTOLIN ACCUHALER) and METOPROLOL for an unknown indication.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VOMITING (throwing up) (seriousness criterion hospitalization), ASTHENIA (weak, cannot stand on his own) (seriousness criterion hospitalization), DYSGEUSIA (sour/foul taste in mouth), FEELING COLD (feeling frozen), NAUSEA (nauseated), CHILLS (chills), MYALGIA (Leg muscles are sore) and HEADACHE (headache). The patient was hospitalized on 21-Apr-2021 due to ASTHENIA and VOMITING. At the time of the report, VOMITING (throwing up), ASTHENIA (weak, cannot stand on his own), DYSGEUSIA (sour/foul taste in mouth), FEELING COLD (feeling frozen), NAUSEA (nauseated), CHILLS (chills), MYALGIA (Leg muscles are sore) and HEADACHE (headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient reports that he "has been given medications in the hospital to treat the symptoms he has been feeling though still feels the same way. He also said hat the hospital is giving him up to be transferred to a Nursing Home today."
Nausea; Chills; Aches; Experienced progressive fever; This is a spontaneous report from a contactable Consumer or other non-HCP (patient) communicated to Pfizer-sponsored program COVAX US Support. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection), dose 1 via an unspecified route of administration on 16Apr2021 (Lot number was not reported), as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date in 2021, the patient experienced progressive fever, nausea, chills and aches. It was reported that the patient got first dose yesterday-16Apr2021 (second dose is on 07May) and on an unknown date, she experienced progressive fever, nausea, chills and aches. She was asking if it would be okay to take Tylenol. The patient outcome of the events was unknown at the time of this report.  No follow-up attempts are needed. Information about lot/batch number cannot be obtained.
Covid; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (Covid) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Covid). At the time of the report, SARS-COV-2 TEST POSITIVE (Covid) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 30-Mar-2021, COVID-19: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient wants to know if they should receive the second dose of the vaccine.Contact preferred by phone or email.
Pt said the veins in his hand on the arm where the shot was given bulged up to his elbow and turned purple. He also had neck pain.
Bexsero given on 7/1/19 @ 2:30 pm increased temps + joint pain to arms + legs developed @ 6 pm. Temp 101 this am (7/2/19) aches persist - unable to attend sports camp starting today
J96.11 CHRONIC HYPOXEMIC RESPIRATORY FAILURE 2/15/2023 MALIGNANT NEOPLASM UNS PART UNS BRONCHUS/LUNG
Systemic: Chest Tightness / Heaviness / Pain-Severe, Systemic: Fatigue-Severe, Systemic: Hypertension-Severe, Systemic: Nausea-Severe, Systemic: Tachycardia-Severe
diarrhea; horrible cramping; Nausea; Stomach issues; vomiting / throwing up; had to stay home from vacation because of it; This case was reported by a consumer via interactive digital media and described the occurrence of nausea in a female patient who received Men B NVS (Meningococcal B vaccine) for prophylaxis.   On 19th August 2021, the patient received Meningococcal B vaccine. In August 2021, less than a week after receiving Meningococcal B vaccine, the patient experienced feeling unwell. On 21st August 2021, the patient experienced nausea, stomach discomfort, vomiting and cramp. On 22nd August 2021, the patient experienced diarrhea. On an unknown date, the outcome of the nausea, stomach discomfort and feeling unwell were unknown and the outcome of the vomiting was recovered/resolved and the outcome of the diarrhea and cramp were not recovered/not resolved.   It was unknown if the reporter considered the nausea, stomach discomfort, vomiting, diarrhea, cramp and feeling unwell to be related to Meningococcal B vaccine.  Additional details provided were as follows: The case was reported by patient's mother. Age at vaccination was not reported. The patient's mother reported that the patient  received the dose of Meningococcal B vaccine on Thursday afternoon and on Saturday she experienced bad reactions including horrible cramping, stomach issues, nausea and vomiting and the next day she was able to keep food down but had diarrhea and cramping was still there. She had to stay home from vacation because of it. Follow-up would not be possible as no contact details available. Note- since the reporter provided details about vaccination day (Thursday) and onset of event (Saturday), so time to onset captured as per these details.
Rash began on 8th day after vaccines. No angioedema, no breathing difficulty. Rash covers from face to toes, does not itch. Benadryl 25 mg had no effect on rash. Private provider unsure of a diagnosis or cause.
20APR92 2PM pt recvd DTP/HIB & 3PM t103; 7PM could not get temp down bet 103-105; reached 105x3; pt had shakes & stopped breathing for short period; had another sz; pt hospitalized; otitis;
It started with a headache, and then i was shaky(but that went away) tired,chills, fever 101.6, blood pressure was really low (I typically have high blood pressure). Major loss of appetite. Vomited twice. Runny nose. Forgetfulness.
Patient was supposed to receive bivalent booster but was mistakenly administered monovalent vaccine due to look-alike error.
Massive swelling of Left upper arm from biceps to elbow. No joint involvement. No induration. No evidence of cellulitis. No fever.
Smallpox 10 days prior. On 3/31 Mn 03 - developed fever up to 103 with headache. Took Tylenol, Mondery? AM, noted red spots in face, neck, chest, back, abdomen - papular looking, variable sizes, irregular borders, some raised as papules, others non-raised. No pustules. Erythema multiform, doubt localized or generalized vaccinia.
Sometime after getting the Pfizer vaccine I noticed that my private area, underarms, and some other things now smell of onion. At first I had thought that it was the drink (Clear American Sparkling Water: Peach Flavor) that was changing my scent because it smelled and tasted heavily of onion. However, my thinking changed when the other flavors of this brand smelled and tasted as they should. My family and friends are not aware of the scent and cannot smell nor taste it. I have also noticed the scent outside my apartment complex on campus. There are no wild onions growing outside, but I can smell the scent when I walk near certain flowers or bushes before it fades away. Upon returning home the scent is still there. Showering controls the scent, but it gets worse throughout the day and makes me very subconscious about how I smell. I do not consume onion on a weekly basis, so the vaccine is the only oddball in my daily diet, so I believe that it is the culprit for this change. I believe that it may have potentially altered my sense of smell opposed to my thinking of my body odor itself changing. I have spoken to my Nurse Practitioner and we've decided to play the waiting game, but she advised me to send in a notice of this to the CDC for additional help if possible.
Swelling, warmth and itching of left upper arm. Site 15 cm X 7 cm.  No drainage or fluctuance.
patient had sore arm and body aches... patient said she may have had chest wall pain but those went away ... patent was advised to follow up with dr today on 9/23/19
Administered second booster dose to pt under age 50 (44 yrs) - no adverse outcomes known
Left leg with profuse swelling and redness approx 1-2 hrs. after vaccines given. Seen in our clinic at 1513 and swelling much less. Still with some redness and hot to touch. Pt very fussy since vaccines. Cries when leg is touched.